Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -74.4% | +188.0% | 1 / 3 | -72.1% | -1.57 pp | -1.31 pp | +7.2% | 0.32 | 8.10 | 144 | −72,1% | 33,3 | −73,6% | 8.10 | 13.57 | −40,3% |
| Pts | 0 | 12 | 4 | 0 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-19)EPS (TTM): 1.235
Financial charts
1.Revenue & growth
VND bn144Q2/26
1.Revenue & growth
VND bn144Q2/26
2.Profit & growth
VND bn29,0Q2/26
3.Profit mix (Penman)
VND bn158Q2/26
4.Margins & cost structure
%26.9%Q2/26
5.Returns & cash cycle
% · days4.9%Q2/26
6.Earnings quality & cash
VND bn-325Q2/26
7.Asset structure
VND bn2.928Q2/26
8.Funding & debt health
VND bn · times2.928Q2/26
9.Revenue backlog
VND bn497Q2/26
10.Valuation
times · %9,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %271Q2/26
Adjusted EPS growth, latest quarter
-74.4%
Average adjusted EPS growth, 3 quarters
-81.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26